Literature DB >> 11231323

"Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation.

R Kruse1, A Rütten, H R Hosseiny-Malayeri, M Bisceglia, W Friedl, P Propping, T Ruzicka, E Mangold.   

Abstract

Muir-Torre syndrome is an autosomal-dominant inherited disorder predisposing to both sebaceous skin tumors and internal neoplasms. In a significant proportion of Muir-Torre syndrome patients skin tumors exhibit microsatellite instability as a hallmark of hereditary nonpolyposis colorectal cancer. Most individuals predisposed to hereditary nonpolyposis colorectal cancer harbor a germline mutation in the DNA mismatch repair genes MSH2 or MLH1. In Muir-Torre syndrome the vast majority of germline mutations have been identified in MSH2. Microsatellite instability in tumor tissue develops after somatic inactivation of the corresponding second mismatch repair allele ("second hit"). So far, the mechanisms of somatic inactivation of the second allele in microsatellite instability positive tumors from patients with known mismatch repair germline mutations are not well understood. We examined whether allele loss (loss of heterozygosity) is a frequent mechanism for inactivation of the second MSH2 allele in a sample of nine microsatellite instability positive skin tumors from eight unrelated Muir-Torre patients with known MSH2 germline mutations. Loss of heterozygosity was determined using microsatellite markers or heteroduplex analysis, respectively. Only one of the nine skin tumors exhibited loss of heterozygosity at the MSH2 locus. Thus, we could show in a sample of sebaceous tumors from patients with genetically proven Muir-Torre syndrome that loss of heterozygosity most probably is not the preferred mode of somatic inactivation of the second MSH2 allele.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231323     DOI: 10.1046/j.1523-1747.2001.01265.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

Review 1.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

2.  Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.

Authors:  Maran J W Berends; Ying Wu; Rolf H Sijmons; Rob G J Mensink; Tineke van der Sluis; Jannet M Hordijk-Hos; Elisabeth G E de Vries; Harry Hollema; Arend Karrenbeld; Charles H C M Buys; Ate G J van der Zee; Robert M W Hofstra; Jan H Kleibeuker
Journal:  Am J Hum Genet       Date:  2002-01       Impact factor: 11.025

3.  Sebaceous neoplasia and Torre-Muir syndrome.

Authors:  A J F Lazar; S Lyle; E Calonje
Journal:  Curr Diagn Pathol       Date:  2007-08

Review 4.  Paraneoplastic dermatological manifestation of gastrointestinal malignancies.

Authors:  Lyubomir A Dourmishev; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

5.  PKD1 intron 21: triplex DNA formation and effect on replication.

Authors:  Hiren P Patel; Lu Lu; Richard T Blaszak; John J Bissler
Journal:  Nucleic Acids Res       Date:  2004-02-27       Impact factor: 16.971

6.  MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms.

Authors:  Adisbeth Morales-Burgos; Jorge L Sánchez; Luz D Figueroa; Wilfredo E De Jesús-Monge; Marcia R Cruz-Correa; Carmen González-Keelan; Cruz María Nazario
Journal:  P R Health Sci J       Date:  2008-12       Impact factor: 0.705

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.